Page 128 - THE EVOLUTION OF EARLY ARTHRITIS AND CARDIOVASCULAR RISK Samina A. Turk

CHAPTER 6
In conclusion, CV risk management is important early in the course of RA, as preventive CV treatment is proven to be effective and should be applied as early as possible(5;25-27;31). However, the timing of CV risk assessment, as well as the availability of different CV risk models, influences the advice on the need for (adaptations of) CV preventive treatment. Further research is needed to determine which risk model is optimal and when in the course of RA it should be applied.
ACKNOWLEDGMENTS We would like to thank all patients, as well as all doctors who enrolled patients in this study, and all research nurses who were involved in patient management.
COMPETING INTERESTS Non declared for this study.
CONTRIBUTORSHIP All authors have substantially contributed to the conception or design of the work; the acquisition, analysis, and interpretation of data for the work. The authors revised the article critically and approved to the final version to be published. All agree to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.
FUNDING This study was performed without funding.
ETHICAL APPROVAL Medical Ethics Committee of the Slotervaart Hospital and Reade approved the protocol; patients gave written informed consent before inclusion, and the study was conducted in accordance with the Declaration of Helsinki/Good Clinical Practice
PROVENANCE AND PEER REVIEW Not commissioned, externally peer reviewed
126